These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 23744100

  • 21. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 22. Predictive potential of age-group cut-off values of N-terminal pro-brain natriuretic peptide in Kawasaki disease.
    Hirai S, Nakamura T, Misawa M.
    Pediatr Int; 2022 Jan; 64(1):e15371. PubMed ID: 36166642
    [Abstract] [Full Text] [Related]

  • 23. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 24. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 25. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
    [Abstract] [Full Text] [Related]

  • 26. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
    Ganguly M, Nandi A, Banerjee P, Gupta P, Sarkar SD, Basu S, Pal P.
    Int J Rheum Dis; 2022 Jan; 25(1):27-31. PubMed ID: 34750969
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 28. N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
    Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
    Cardiol Young; 2015 Oct; 25(7):1311-8. PubMed ID: 25544036
    [Abstract] [Full Text] [Related]

  • 29. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease.
    Kato M, Ayusawa M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2018 Apr; 60(4):342-348. PubMed ID: 29350882
    [Abstract] [Full Text] [Related]

  • 30. Usefulness of Age-Stratified N-Terminal Prohormone of Brain Natriuretic Peptide for Diagnosing Kawasaki Disease.
    Lee SH, Song ES, Yoon S, Hong S, Cho HJ, Yang EM, Eom GH, Kang G, Cho YK.
    Dis Markers; 2017 Apr; 2017():6263121. PubMed ID: 29358841
    [Abstract] [Full Text] [Related]

  • 31. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
    [Abstract] [Full Text] [Related]

  • 32. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
    Hashimoto I.
    Pediatr Int; 2019 Jul 27; 61(7):641-646. PubMed ID: 31132210
    [Abstract] [Full Text] [Related]

  • 33. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 34. Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
    Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M.
    Pediatrics; 2012 Jan 16; 129(1):e17-23. PubMed ID: 22144699
    [Abstract] [Full Text] [Related]

  • 35. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K, Wakejima Y, Gau M, Kiguchi T, Matsuda N, Takasawa R, Takasawa K, Nishioka M, Shimohira M.
    Int J Rheum Dis; 2018 Mar 16; 21(3):746-754. PubMed ID: 29105337
    [Abstract] [Full Text] [Related]

  • 36. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec 16; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 37. Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014.
    Kim MK, Song MS, Kim GB.
    Korean Circ J; 2018 Jan 16; 48(1):71-79. PubMed ID: 29171205
    [Abstract] [Full Text] [Related]

  • 38. Marker of T-cell activation is elevated in refractory Kawasaki disease.
    Suzuki H, Suenaga T, Takeuchi T, Shibuta S, Yoshikawa N.
    Pediatr Int; 2010 Oct 16; 52(5):785-9. PubMed ID: 20487370
    [Abstract] [Full Text] [Related]

  • 39. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L, Chen Y, Zhong S, Li Y, Dai X, Di Y.
    Indian Pediatr; 2015 Jun 16; 52(6):477-80. PubMed ID: 26121721
    [Abstract] [Full Text] [Related]

  • 40. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T, Takeshita S, Kawamura Y, Kinoshita K, Nakatani K, Iwashima S, Takizawa Y, Hirono K, Mori K, Yoshida Y, Nonoyama S.
    Heart Vessels; 2020 Oct 16; 35(10):1463-1472. PubMed ID: 32449049
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.